SCHEMBL4961177

SCHEMBL4961177

C=C(c1ccc2ccc(Cl)cc2n1)c1ccccc1C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.46
▸ SMN1; SMN2 Q16637 6/20 0.46
▸ MEN1 O00255 3/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ RAB9A P51151 3/20 0.46
▸ TP53 P04637 2/20 0.46
▸ CYP2C9 P11712 2/20 0.46
▸ HPGD P15428 2/20 0.46
▸ NPC1 O15118 2/20 0.46
▸ CYP1A2 P05177 2/20 0.46
▸ MGAM O43451 1/20 0.44
▸ CNR2 P34972 1/20 0.43
▸ NR4A1 P22736 1/20 0.42
▸ POLB P06746 1/20 0.41
▸ GAA P10253 4/20 0.40
▸ MAPT P10636 3/20 0.40
▸ LMNA P02545 2/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ GRIK1 P39086 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5810767 0.81 MEN1 (0.34) ALDH1A1SMN1; SMN2MEN1KMT2ARAB9A
SCHEMBL8604002 0.81 CNR2 (0.38) ALDH1A1SMN1; SMN2MEN1KMT2ARAB9A
SCHEMBL3228023 0.80 CNR2 (0.43) ALDH1A1SMN1; SMN2MEN1KMT2ARAB9A
SCHEMBL22777233 0.78 MGAM (0.58) ALDH1A1SMN1; SMN2MEN1KMT2ARAB9A
SCHEMBL29527233 0.78 MGAM (0.58) ALDH1A1SMN1; SMN2MEN1KMT2ARAB9A
SCHEMBL2020026 0.72 TDP1 (0.33) ALDH1A1SMN1; SMN2MEN1KMT2ANPC1
SCHEMBL28603923 0.71 NR4A1 (0.68) ALDH1A1MEN1KMT2ARAB9ACYP2C9
SCHEMBL18463776 0.71 NR4A2 (0.43) ALDH1A1SMN1; SMN2MEN1KMT2ANPC1
SCHEMBL9757049 0.70 NR4A2 (0.41) ALDH1A1SMN1; SMN2MEN1KMT2ACNR2
SCHEMBL4961173 0.70 MEN1 (0.53) ALDH1A1SMN1; SMN2MEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008035379-A2 PROCESS FOR AND INTERMEDIATES OF LEUKOTRIENE ANTAGONISTS APTUIT LAURUS PRIVATE LIMITED (IN) 2008-03-27 — — WO claimed
Send feedback